ICMR nod to Vishat Diagnostics COVID-19 antigen testing kit priced at Rs 425
New Delhi: Mumbai-based firm Vishat Diagnostics on Friday said it has received approval from the Indian Council of Medical Research (ICMR) for supplying COVID-19 rapid testing antigen kit manufactured by Coris BioConcept.
The company plans to launch the testing kit named, 'COVID-19 Ag Respi-Strip' at a price of Rs 425, Vishat Diagnostics said in a statement.
Read Also: Order Govt to increase COVID-19 testing: Ahmedabad Medical Association urges HC
The kit tests for antibodies in users to determine whether they have had coronavirus infection in the past.
"With COVID-19 Ag Respi-Strip, we are bringing CE certified (allowed to sell in European Economic Area) and ICMR approved kits at affordable prices, which is also our company's driving force for all other product lines," Vishat Diagnostics MD Pratik Chaitala said.
At a time when India is touching its peak in daily numbers of cases, it becomes critical to rapidly increase testing, he added.
COVID-19 Ag Respi-Strip can show results in a span of 15 minutes, the statement said.
The kit has been developed by Belgium-based firm Coris BioConcept, and is used in several European countries and in North America, it added.
Read Also: Bengaluru Doctor succumbs to COVID, private hospitals face heat for allegedly denying admission
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.